0001615774-17-003293.txt : 20170621
0001615774-17-003293.hdr.sgml : 20170621
20170621170041
ACCESSION NUMBER: 0001615774-17-003293
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170620
FILED AS OF DATE: 20170621
DATE AS OF CHANGE: 20170621
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 509 MADISON AVE. - SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 1-800-849-7894
MAIL ADDRESS:
STREET 1: 509 MADISON AVE. - SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MATHER CHARLES E IV
CENTRAL INDEX KEY: 0001563422
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 17923365
MAIL ADDRESS:
STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP
STREET 2: 509 MADISON AVE., SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
4
1
s106635_form4.xml
OWNERSHIP DOCUMENT - CHARLES E. MATHER IV
X0306
4
2017-06-20
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001563422
MATHER CHARLES E IV
C/O TONIX PHARMACEUTICALS HOLDING CORP
509 MADISON AVE., SUITE 306
NEW YORK
NY
10022
1
0
0
0
Stock Option
4.18
2017-06-20
4
A
0
20000
0.00
A
2018-06-20
2027-06-20
Common Stock
20000
20000
D
The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan.
/s/Jessica Morris, Attorney-in-Fact
2017-06-21